The global Botulinum Toxin Market Growth Accelerated by Rising Aesthetic Applications
Botulinum toxin is a neurotoxic protein produced by the
bacterium Clostridium botulinum. Botulinum toxin is extensively used in
cosmetic procedures for aesthetic applications such as wrinkle reduction and is
particularly effective in reducing facial lines such as frown lines, forehead
lines, and crow's feet. Its ability to temporarily paralyze muscles by blocking
the release of acetylcholine at neuromuscular junctions and thereby reducing
muscle contractions results in smoothing of wrinkles. Moreover, the non-invasive
nature and negligible side effects have further propelled its demand for
aesthetic procedures.
The global Botulinum Toxin Market is estimated to be valued
at US$ 7.61 Bn in 2023 and is expected to exhibit a CAGR of 5.2% over the
forecast period 2023 to 2030, as highlighted in a new report published by
Coherent Market Insights.
Market key trends:
Growing popularity of non-surgical aesthetic procedures among millennials has
fueled the rise of novel applications of botulinum toxin. Increasing social
media influences have made millennials more aware about facial aesthetics and
driven the uptake of non-invasive treatments such as injections of botulinum
toxin to delay signs of aging. This has encouraged manufacturers to develop new
formulations and dosage forms such as topical gels to penetrate deeper layers
of the skin and treat dynamic wrinkles as well as static ones. Such product
innovations are expected to further increase access and expand the market for
botulinum toxin in the coming years.
Segment Analysis
The global botulinum
toxin market is dominated by the therapeutic applications segment. This
segment accounts for the largest share as botulinum toxin is widely used to
treat medical conditions such as chronic migraines, excessive underarm
sweating, overactive bladder, and cervical dystonia. The cosmetic applications
segment is the fastest growing segment. There is increasing demand for
botulinum toxin injections to reduce wrinkles and relax frown lines and
forehead lines.
Key Takeaways
The global botulinum toxin market is expected to witness high growth over the
forecast period of 2023 to 2030. The global Botulinum Toxin Market is estimated
to be valued at US$ 7.61 Bn in 2023 and is expected to exhibit a CAGR of 5.2%
over the forecast period 2023 to 2030.
Regional analysis
North America is expected to remain the largest as well as the fastest growing
regional market for botulinum toxin during the forecast period. Rise in demand
for anti-aging treatments and increase in aesthetic procedures being performed
in countries like the US and Canada are some major factors contributing to the
growth of the botulinum toxin market in North America. Moreover, FDA approval
and commercial launches of new botulinum toxin products are also expected to
support the market growth.
Key players
Key players operating in the botulinum toxin market are Ipsen group, Allergan
Plc., Medytox Inc., Merz GmbH and Co. KGaA, US Worldmed, LLC, Lanzhou Institute
of Biological Products Co. Ltd., Revance Therapeutics, Inc., and Daewoong
Pharmaceutical Co., Ltd. Allergan Plc. and Ipsen group are the largest players
in the botulinum toxin market, together accounting for over 65% of the total global
market share.
Get more
insights on this topic:
Third
Generation Sequencing Market

Comments
Post a Comment